Denosumab: Regulatory History

2 source-based articles maintained by the HealthRX.com Editorial Team.

2articles

1topic areas covered

May 27, 2026latest review

Denosumab: Regulatory History library

Showing 2 of 2 clinical reviews.

Clinical ReviewsMay 27, 2026

Prolia (Denosumab) FDA Approval History

A detailed regulatory timeline of denosumab (Prolia/Xgeva) from initial FDA approval through post-market safety updates, label expansions, and biosimilar developments.

Clinical ReviewsJul 29, 2026

Prolia (Denosumab): FDA Pipeline, Label Updates, and Next-Generation Developments

Current 2026 review of the Prolia FDA label, severe hypocalcemia boxed warning, discontinuation risk, approved denosumab biosimilars, and treatment planning.